Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Antimicrobial resistance

New approach to target antimicrobial resistance

Methicillin-resistant staphylococcus aureus

Source: Centres for Disease Control and Prevention

Resistant bacteria, such as methicillin-resistant staphylococcus aureus (pictured), may be targeted in a new way, suggest researchers.

Current antibiotics tend to be broad-spectrum, leading to indiscriminate killing of commensal bacteria and accelerated evolution of drug resistance.

These pitfalls may be avoided with a new antimicrobial approach that imposes “direct evolutionary pressure at the gene level by using efficiently delivered, programmable RGNs [RNA-guided nucleases]”. Known as CRISPR-associated Cas, the system is part of the bacterium’s own defence strategy that triggers cell death or plasmid loss upon detection of genetic signatures associated with virulence or antibiotic resistance.

By manipulating the system, Timothy Lu and colleagues at Massachusetts Institute of Technology were able to disarm genes involved in determining antibiotic resistance and virulence, resulting in the death of more than 99% of previously resistant bacteria, according to research in Nature Biotechnology[1] (online, 21 September 2014). The team is now testing the approach in mice.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2014.20066622

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.